Download Your Complimentary Copy of the Agenda
The 3rd Cell & Gene Therapy Pricing & Reimbursement Summit is your unique forum to learn, network, and partner with the leaders reshaping the commercialization journey for cell and gene therapies.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Explore the 2026 Event Program to See What’s In Store:
Major Payer & Policy Representation
Hear directly from leaders at Blue Cross Blue Shield, Oklahoma Healthcare Authority, and other key stakeholders shaping coverage decisions, as they share how evidence expectations, reimbursement pathways, and policy frameworks are evolving
Real-World Commercialization Case Studies
Learn from approved companies including Autolus, Orchard Therapeutics, and Genetix Biotherapeutics as they break down what drove uptake, what slowed access, and how they navigated real payer and provider challenges
Focused Insights on the CGT Access Model
Gain practical understanding of outcomes-based agreements and the Cell & Gene Therapy Access Model from the Oklahoma Healthcare Authority, including how payment structures work in practice and what this means for future pipeline assets
The Only Dedicated CGT Pricing & Reimbursement Forum
Join a focused room of biopharma, payers, policymakers, and providers at the only meeting built exclusively to address pricing, reimbursement, and access challenges for cell and gene therapies